Learning objectives
- To learn about the evidence-base for lung cancer screening and novel diagnostic modalities
- To learn about the management of early stage NSCLC and use of adjuvant treatments
- To understand the role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
- To learn about the management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
- To understand the role of immune-checkpoint blockade for lung cancer and to learn about novel immunotherapies
- To learn about treatment of NSCLC with oligometastatic disease
- To learn about the systemic treatment of mesothelioma and small cell lung cancer
- To learn about the role of supportive and palliative care for thoracic malignancies
Application closed on 6 December 2016
Více informací na stránkách ESMO
- Přidat do kalendáře: 2017-03-01 00:00:00 2017-03-03 23:59:59 Europe/Prague ESMO Preceptorship on Lung Cancer 2017 Manchester, United Kingdom